KCT0003997尚未招募未知
Clinical Trial to Assess the Effectiveness and to Safety of UC in the Patients with Ischemic Stroke: a multi-center randomized controlled pilot trial)
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •(1) Men and women who are not pregnant nor breastfeeding, aged 19 to 80 years
- •(2) Patients diagnosed with acute ischemic stroke in brain image(MR or CT)
- •(3) Patients participating within 90 days of the onset
- •(4) Patients with upper or lower limb weakness (Fugl-Meyer Assessment (FMA) motor score = 55 and 1= Medical Research Council Scale score (at least one arm or leg motor power grade) =4)
- •(5) Patients with mild to moderate ischemic stroke (4= Korean version of the National Institute of Health Stroke Scale (K-NIHSS) score =15)
- •(6) modified Rankin Scale (mRS) score before the recent ischemic stroke =1
- •(7) Subject who have no communication problems and voluntary agree to participate
排除标准
- •(1) Patients with motor weakness caused by previous stroke
- •(2) Patients diagnosed with degenerative brain disease(e.g., Parkinson's disease, Alzheimer's disease)
- •(3) Patients diagnosed with hemorrhagic stroke(intracranial hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage) in brain image(MR or CT)
- •(4) Taking amphetamine, Selective Serotonin Reuptake Inhibitors(SSRI), or antipsychotic medication
- •(5) Patients with other brain disease (e.g., brain tumor, traumatic brain injury, arteriovenous malformation, moyamoya disease, and ischemic stroke caused by these disease, etc.)
- •(6) Previous history of brain surgery
- •(7) Patients who already have motor weakness due to other disease
- •(8) Unstable vital signs at screening (e.g., systolic blood pressure (sBP) =160mmHg, even though taking antihypertensive drugs)
- •(9) Serious disease(e.g., liver disease, kidney disease, severe heart failure( = New York Heart Association classification (NYHA) Class III), etc.)
- •(10) Taking drugs that can cause liver or renal dysfunction
- •(11) Patients who diagnosed or treated cancer within 6 months
- •(12) Taking other herbal medicines within 4 weeks before participating in the clinical trial
- •(13) Blood test meets the following criteria:
- •1) aspartate aminotransferase (AST) or alanine aminotransferase (ALT) level = x2 of normal range
- •2) Creatinine > 2.0mg/dL
- •3) Hemoglobin < 10g/dL, Hct < 25%, Platelet < 100,000/mm3
- •(14) Participation in other clinical studies within 30 days
- •(15) Participants who are judged by investigator to be nonconformity for participation in the trial for other reasons
研究者
相似试验
招募中
不适用
Contrast Enhanced Ultrasonography-guided Sentinel Lymph Node Biopsy after Introducing Twirl Breast Marker for Axillary Lymph Node-positive Breast CancerD001943Breast cancerJPRN-jRCTs051210034Miyake Tomohiro20
招募中
2 期
A Clinical Trial To Evaluate The Effectiveness Of Vasa Avaleha In Respiratory Symptoms As A Sequelae Of FeverCTRI/2023/07/055016I
招募中
2 期
A Clinical Trial To Evaluate The Action OF Duralabhadi Decoction In The Management Of Urinary Tract Infections.CTRI/2023/07/055121I
招募中
2 期
Effect of levetiracetam and topiramate in infantile spasmsIRCT20091027002639N21Yazd University of Medical Sciences60
进行中（未招募）
Unknown
The effectiveness and safety of oral adhesive bandage for extraction wound managementWound management in tooth extractionOral HealthISRCTN11589028Wuhan University120